A New Era of Smart Large-Format Visuals
TAIPEI, Nov. 18, 2025 /PRNewswire/ -- As a global leader in display technology, Optoma unveils its brand-new All-in-One LED display solution, marking the beginning of a new era where large-format displays become seamlessly intelligent. Every aspect of design, performance, and management has been elevated to deliver a truly immersive experience that impresses the moment you power on.
At the heart of this launch is the ProScene AIO dvLED series, available in 108-, 135-, and 163-inch models. Powered by Flip-Chip + COB packaging technology, an integrated Android system, and dual intelligent management platforms, the series delivers a seamless, calibration-free, and hassle-free large-display ecosystem. Whether for corporate showcases, educational engagement, or stage presentations, content can be presented faster, clearer, and more elegantly than ever.
Minimalist Design × Flagship Visuals — Stunning from the First Power-On
The AIO dvLED series delivers professional-grade visuals with Full HD resolution and high brightness for sharper text and more dynamic images—instantly elevating presentations and exhibitions to a flagship level.
Each display undergoes precise individual color calibration before leaving the factory, ensuring peak performance right out of the box.
With its Flip-Chip LED architecture enhancing brightness and heat dissipation, and COB packaging for added protection and reduced dust intrusion, the series offers durability for long-term stability. The anti-glare matte surface maintains crisp visibility even in bright environments, combining premium aesthetics with reliable endurance.
Rapid Installation × High Flexibility — Large-Format Deployment, Simplified
The AIO dvLED lineup features lightweight pre-assembled modules and an ultra-slim design, significantly shortening installation time.
Hot-swappable modules and magnetic front-access maintenance make servicing as simple as snapping pieces into place.
With a built-in Android system and 64GB of local storage, users can upload content, create custom interfaces, and set schedules—all without requiring an external computer—creating a flexible, intelligent display environment.
Dual Intelligent Platforms × Cloud Management — Smarter, Centralized Control
Optoma's integrated ecosystem brings professional management and collaboration together through two powerful platforms:
OMS (Optoma Management Suite) + OSS (Optoma Solution Suite).
- OMS / OMSC® Cloud Management
Enables remote monitoring, scheduling, content updates, and 24/7 alerts—empowering IT teams to manage multi-site deployments with ease. - OSS Collaboration Platform
Designed as an interactive hub supporting screen sync, multi-user annotation, and wireless casting, enabling seamless and intuitive collaboration.
For advanced multi-display applications, the system can be paired with the HQScene200 dvLED controller, supporting 4K input, image stitching, and synchronized multi-window output.
Wireless Casting × Multi-User Collaboration — Interaction Made Effortless
The built-in Display Share system supports wireless casting across Windows, macOS, Android, and iOS, enabling up to four split-screen views simultaneously ideal for business meetings and classroom engagement.
With up to 120W of integrated audio output, the sound system is fully built into the display, eliminating extra cabling or external speakers while delivering a complete immersive audiovisual experience.
Full Size Range × Built for Every Space
The Optoma All-in-One LED series offers three sizes to match diverse environments:
- FHDC108: Perfect for mid-size meeting rooms and classrooms
- FHDC135: The ideal choice for corporate presentations and business settings
- FHDC163: A commanding centerpiece for stages, exhibitions, and worship spaces
From professional offices to public venues, the series redefines what large-format displays can achieve through superior image quality and intelligent management.
For more details on Optoma All-in-One LED Display Solution, please visit our official website：https://www.optoma.asia/products/All-in-one-solutions
About Optoma
As a global leader in display solutions, Optoma is committed to delivering efficient, innovative display technologies and solutions across all industries. From projectors and monitors to intelligent display systems, Optoma adheres to its core philosophy of "continuous innovation," striving to advance display technology and its applications, and to provide customers with outstanding visual experiences and management performance.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Optoma Introduces Advanced All-in-One LED Display Solution with Flip-Chip COB and Dual Smart Platforms
|
NEW YORK, March 3, 2026 /PRNewswire/ -- IOPE, a clinical-grade skincare brand from Amorepacific and a leader in Korean anti-aging innovation, officially debuts in the U.S. market today. Backed by 30 years of research and expertise in Korea, the United States marks the brand's second global market through strategic retail partnerships at Sephora. IOPE launches on Sephora.com today, rolling out to Sephora stores later in the month.
"We are thrilled to bring IOPE to the U.S. after decades of unparallelled performance in Korea," said Giovanni Valentini, CEO Amorepacific North America. "Consumers are more discerning than ever, prioritizing clinically proven efficacy and visible results in an increasingly saturated skincare market. With IOPE, we are introducing targeted skincare solutions, that are clinically tested, at a competitive price point."
For three decades, IOPE has been at the forefront of Korean anti-aging research, grounded in rigorous clinical testing. The brand has pioneered advancements in key active ingredients, including PDRN, stabilized Vitamin C, and innovative retinol stabilization technology that is supported by 26 Korean patents and more than a dozen scientific publications. As Korean skincare continues to set the global standard for innovation and performance, IOPE stands among the category's most respected leaders.
IOPE's professional treatment–inspired formulations are rooted in evidence-based research and designed to deliver visible improvements across key skin concerns, including texture, firmness, brightness, and overall vitality, redefining expectations for at-home skincare performance.
IOPE enters the U.S. market with nine targeted products, featuring the brand's transformative XMD, Retinol RX™, Vitamin C, and PDRN Caffeine collections. Their newest innovations draw inspiration from Korea's viral skin booster treatments and are clinically proven to deliver professional treatment-level results at home:
- XMD Stem III Clinical Recovery Serum ($59): Inspired by Korea's viral professional PDRN treatments, this advanced serum was clinically tested to deliver professional PDRN treatment–level results across six key metrics, including increased volume, improved elasticity, and enhanced texture – without the downtime or discomfort associated with in-office treatments. The breakthrough formula is powered by 92.3% PDRN H.A.™ Liposome Complex, featuring PDRN, micro-molecular hyaluronic acid, and a soothing allantoin-based complex.
- Retinol RX™ 2% Reti-jection™ Serum ($57): Formulated with a 2% concentration of Retinol RX™ – IOPE's proprietary retinoid complex – this high-performance serum is designed to optimize efficacy while reducing irritation. The formula features retinol-infused spicules to enhance absorption. The serum is clinically proven to deliver collagen booster treatment–level results, including reduced look of wrinkles, minimized pore appearance, and enhanced radiance.
IOPE products range in price from $6.50 for a single sheet mask to $69 for XMD Stem III Clinical Recovery Cream.
IOPE is available now at Sephora.com and will be available in Sephora stores nationwide starting March 13, 2026.
About AMOREPACIFIC:
Established in 1945, Amorepacific is Korea's leading beauty company, powered by a global portfolio of category defining skincare, makeup, haircare, and wellness brands. Rooted in pioneering research that began with Korea's first cosmetics lab, the company continues to shape the future of K-beauty through bio-driven, longevity-focused innovation.
NEW YORK, March 3, 2026 /PRNewswire/ -- IOPE, a clinical-grade skincare brand from Amorepacific and a leader in Korean anti-aging innovation, officially debuts in the U.S. market today. Backed by 30 years of research and expertise in Korea, the United States marks the brand's second global market through strategic retail partnerships at Sephora. IOPE launches on Sephora.com today, rolling out to Sephora stores later in the month.
"We are thrilled to bring IOPE to the U.S. after decades of unparallelled performance in Korea," said Giovanni Valentini, CEO Amorepacific North America. "Consumers are more discerning than ever, prioritizing clinically proven efficacy and visible results in an increasingly saturated skincare market. With IOPE, we are introducing targeted skincare solutions, that are clinically tested, at a competitive price point."
For three decades, IOPE has been at the forefront of Korean anti-aging research, grounded in rigorous clinical testing. The brand has pioneered advancements in key active ingredients, including PDRN, stabilized Vitamin C, and innovative retinol stabilization technology that is supported by 26 Korean patents and more than a dozen scientific publications. As Korean skincare continues to set the global standard for innovation and performance, IOPE stands among the category's most respected leaders.
IOPE's professional treatment–inspired formulations are rooted in evidence-based research and designed to deliver visible improvements across key skin concerns, including texture, firmness, brightness, and overall vitality, redefining expectations for at-home skincare performance.
IOPE enters the U.S. market with nine targeted products, featuring the brand's transformative XMD, Retinol RX™, Vitamin C, and PDRN Caffeine collections. Their newest innovations draw inspiration from Korea's viral skin booster treatments and are clinically proven to deliver professional treatment-level results at home:
- XMD Stem III Clinical Recovery Serum ($59): Inspired by Korea's viral professional PDRN treatments, this advanced serum was clinically tested to deliver professional PDRN treatment–level results across six key metrics, including increased volume, improved elasticity, and enhanced texture – without the downtime or discomfort associated with in-office treatments. The breakthrough formula is powered by 92.3% PDRN H.A.™ Liposome Complex, featuring PDRN, micro-molecular hyaluronic acid, and a soothing allantoin-based complex.
- Retinol RX™ 2% Reti-jection™ Serum ($57): Formulated with a 2% concentration of Retinol RX™ – IOPE's proprietary retinoid complex – this high-performance serum is designed to optimize efficacy while reducing irritation. The formula features retinol-infused spicules to enhance absorption. The serum is clinically proven to deliver collagen booster treatment–level results, including reduced look of wrinkles, minimized pore appearance, and enhanced radiance.
IOPE products range in price from $6.50 for a single sheet mask to $69 for XMD Stem III Clinical Recovery Cream.
IOPE is available now at Sephora.com and will be available in Sephora stores nationwide starting March 13, 2026.
About AMOREPACIFIC:
Established in 1945, Amorepacific is Korea's leading beauty company, powered by a global portfolio of category defining skincare, makeup, haircare, and wellness brands. Rooted in pioneering research that began with Korea's first cosmetics lab, the company continues to shape the future of K-beauty through bio-driven, longevity-focused innovation.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
IOPE LAUNCHES IN THE U.S.
